Futura hails product progress 08/09/2010
Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.
Video streaming specialist Forbidden Technologies is launching a new consumer video-editing package with Italian-owned internet and broadband group Tiscali.
AIM-quoted Forbidden has formed a partnership with Tiscali to launch its new 'Clesh' (clip load edit share) package. The company argues Clesh, a scaled-down version of its FORscene package for professional post-production broadcasters, is one of the first applications providing a 'truly interactive user experience through the internet'.
Clesh is designed to enable consumers to 'experience the functionality and features of FORscene' to edit and share their own video and mobile phone footage on the internet, through a home computer. Stephen Streater, chief executive of Wimbledon-based Forbidden, says 'using Clesh, consumers can create their own videos and publish them for viewing on the web or on mobile phones from almost any computer'.
Shares in Forbidden, which lost £642,500 in 2004 last year and a further £345,000 in the first half of 2005, were floated on AIM at 20p in 2000. After hitting 73.5p in 2003, they fell to 17.5p last October.
Since then the price has rallied somewhat. Forbidden now trades at 29.5p, up 3.5p this morning, valuing the company at £22 million.
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.
Dana Petroleum says its shares are worth between £22.70p and £24.65p to support its opposition to Korea National Oil Corporation's bid at £18.
Online antibody distributor Abcam fears public spending cuts might dampen growth after lifting annual pre-tax profits 58.4 per cent to £25.8 million.